Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections

Yulia Desheva; Galina Leontieva; Tatiana Kramskaya; Kornelia B. Grabovskaya; Vadim Karev; Andery Mamontov; Petr Nazarov; Alexander Suvorov

doi:10.1371/journal.pone.0218544

Loading metrics

Open Access

Peer-reviewed

Research Article

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections

Yulia Desheva ,

Roles Conceptualization, Supervision, Writing – original draft

* E-mail: desheva@mail.ru, y.desheva@spbu.ru

Affiliations Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation, Saint Petersburg State University, Saint Petersburg, Russian Federation

http://orcid.org/0000-0001-9794-3520

⨯
Galina Leontieva,

Roles Conceptualization, Investigation, Writing – review & editing

Affiliation Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation

http://orcid.org/0000-0002-9876-6594

⨯
Tatiana Kramskaya,

Roles Data curation, Investigation, Methodology

Affiliation Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation
⨯
Kornelia B. Grabovskaya,

Roles Investigation

Affiliation Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation
⨯
Vadim Karev,

Roles Investigation

Affiliation Federal State Budgetary Institution "Research institute of children's diseases", Saint Petersburg, Russian Federation
⨯
Andery Mamontov,

Roles Investigation

Affiliation Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation
⨯
Petr Nazarov,

Roles Conceptualization, Investigation, Methodology

Affiliation Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation

http://orcid.org/0000-0002-4169-9968

⨯
Alexander Suvorov

Roles Conceptualization, Supervision

Affiliations Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation, Saint Petersburg State University, Saint Petersburg, Russian Federation
⨯

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections

Yulia Desheva,
Galina Leontieva,
Tatiana Kramskaya,
Kornelia B. Grabovskaya,
Vadim Karev,
Andery Mamontov,
Petr Nazarov,
Alexander Suvorov

Published: June 25, 2019
https://doi.org/10.1371/journal.pone.0218544

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Pneumococcus
Is the Subject Area "Pneumococcus" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Influenza
Is the Subject Area "Influenza" applicable to this article?

Thanks for your feedback.
Influenza viruses
Is the Subject Area "Influenza viruses" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.
Streptococcal infections
Is the Subject Area "Streptococcal infections" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Bacterial diseases
Is the Subject Area "Bacterial diseases" applicable to this article?

Thanks for your feedback.